Interleukin-6 (-174G/C), Interleukin-1β (-511 C/T), and Apolipoprotein B-100 (2488 C/T) Gene Polymorphism in Pre-Eclampsia

被引:0
|
作者
Najeeb, Muhammad Naveed [1 ,2 ]
Munir, Umaira [2 ,3 ]
Hamza, Muhammad Ameer [3 ]
Mehmood, Sadia [4 ]
Qureshi, Javed Anver [1 ]
Maqbool, Tahir [1 ]
机构
[1] Univ Lahore, Inst Mol Biol & Biotechnol, Lahore 40100, Punjab, Pakistan
[2] Quaid e Azam Med Coll, Bahawalpur 63100, Punjab, Pakistan
[3] Shahida Islam Med Coll, Lodhran 59320, Punjab, Pakistan
[4] Bakhtawar Ameen Med Coll, Multan, Punjab, Pakistan
来源
MEDICINA-LITHUANIA | 2024年 / 60卷 / 08期
关键词
pre-eclampsia; gestational hypertension; proteinuria; restriction fragment length polymorphism; Hardy-Weinberg equilibrium; PREGNANCY; RISK; CYTOKINES; TERM;
D O I
10.3390/medicina60081307
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: Pre-eclampsia (PE) is a pregnancy-specific condition characterized by significant health risks for pregnant women worldwide due to its status as a multi-organ disorder. High blood pressure (hypertension) with or without proteinuria is usually considered an initial clinical sign of PE. The pathogenesis of pre-eclampsia is highly complex and likely involves multiple factors, including poorly developed uterine spiral arterioles, immunological issues, placental ischemia or infarction, and genetic abnormalities. Inflammatory cytokine production, regulated by cytokine gene polymorphisms, is one of the factors likely contributing to the development of PE. The present study aimed to assess IL-6, IL-1 beta, and Apo B-100 gene polymorphism and to evaluate the association of these polymorphisms with PE. Materials and Methods: This cross-sectional observational study involved 99 participants aged 16 to 45 years from Bahawal Victoria Hospital Bahawalpur, Punjab, Pakistan. The participants were divided into three groups: Group 1 (PE with severe hypertension), Group 2 (PE with hypertension), and Group 3 (control), each comprising 33 individuals. Maternal blood samples were collected, DNA was extracted, and molecular genetic analysis of the IL-6, IL-1 beta, and Apo B-100 genes was performed using the PCR-RFLP method. Allelic frequencies were compared, and statistical analysis was conducted using SPSS 25, applying the Hardy-Weinberg equation and chi-square test to evaluate the results. Results: There are differences in the distribution of allelic frequencies for IL-6 -174G/C (CC, GC, GG), IL-1 beta-511C/T (CC, CT, TT), and Apo B-100 2488 C/T (CC, CT, TT) between pre-eclamptic patients and the control group. The analysis using the Hardy-Weinberg equilibrium and chi-square test showed an association between the IL-6-174 G/C polymorphism and the severity of pre-eclampsia. Conclusions: The polymorphisms of the IL-6, IL-1 beta, and Apo B-100 genes revealed different alleles. The IL-6 gene alone was found to be in disequilibrium according to the Hardy-Weinberg equation, indicating a potential link to the severity of pre-eclampsia in the population studied.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Interleukin-6 - 174G/C polymorphism and ischemic stroke a systematic review
    Tso, Amy R.
    Merino, Jose G.
    Warach, Steven
    STROKE, 2007, 38 (11) : 3070 - 3075
  • [2] The Association of 174G>C Polymorphism on Interleukin-6 Gene With Type 2 Diabetes Mellitus
    Papaoikonomou, Stavroula
    Tentolouris, Nicholas
    Tousoulis, Dimitris
    Papadogiannis, Dimitris
    Miliou, Antigoni
    Hatzis, George
    Papageorgiou, Nikolaos
    Stefanadis, Christodoulos
    DIABETES, 2013, 62 : A717 - A717
  • [3] The-511 C/T polymorphism of the interleukin-1β gene in female athletes
    Casabellata, G
    Di Santolo, M
    Cauci, S
    BRAIN BEHAVIOR AND IMMUNITY, 2005, 19 (05) : 469 - 469
  • [4] Interleukin-6 -: 174G/C polymorphism and longevity:: a follow-up study
    Hurme, M
    Lehtimäki, T
    Jylhä, M
    Karhunen, PJ
    Hervonen, A
    MECHANISMS OF AGEING AND DEVELOPMENT, 2005, 126 (03) : 417 - 418
  • [5] The -174 G/C gene polymorphism in interleukin-6 and breast cancer
    Santos, SCL
    Bicalho, MD
    Cavalli, IJ
    Lima, RS
    Ribeiro, EMSF
    HUMAN IMMUNOLOGY, 2005, 66 : S42 - S42
  • [6] Transforming growth factor-1 869T/C, but not interleukin-6 174G/C, polymorphism associates with hypertension in rheumatoid arthritis
    Panoulas, V. F.
    Douglas, K. M. J.
    Smith, J. P.
    Stavropoulos-Kalinoglou, A.
    Metsios, G. S.
    Nightingale, P.
    Kitas, G. D.
    RHEUMATOLOGY, 2009, 48 (02) : 113 - 118
  • [7] The Interleukin-6 — 174G/C Promoter Polymorphism Is Not Associated With Endometriosis in South Indian Women
    Manjula Bhanoori
    Kusuma Arvind Babu
    Mamata Deenadayal
    Stephen Kennedy
    Sisinthy Shivaji
    The Journal of the Society for Gynecologic Investigation: JSGI, 2005, 12 : 365 - 369
  • [8] INTERLEUKIN-6 (-174G/C) POLYMORPHISM, RS1800795, IN ESRD PATIENTS' OUTCOME
    Rocha, Susana
    Valente, Maria Joao
    Coimbra, Susana
    Catarino, Cristina
    Rocha-Pereira, Petronila
    Oliveira, Jose Gerardo
    Madureira, Jose
    Fernandes, Joao Carlos
    Faria, Maria do Sameiro
    Miranda, Vasco M. P.
    Belo, Luis
    Santos-Silva, Alice
    Bronze-da-Rocha, Elsa
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [9] -174G/C interleukin-6 gene promoter polymorphism predicts therapeutic response to etanercept in rheumatoid arthritis
    Ivan Jančić
    Nevena Arsenović-Ranin
    Mirjana Šefik-Bukilica
    Sladjana Živojinović
    Nemanja Damjanov
    Vesna Spasovski
    Sanja Srzentić
    Biljana Stanković
    Sonja Pavlović
    Rheumatology International, 2013, 33 : 1481 - 1486
  • [10] -174G/C interleukin-6 gene promoter polymorphism predicts therapeutic response to etanercept in rheumatoid arthritis
    Jancic, Ivan
    Arsenovic-Ranin, Nevena
    Sefik-Bukilica, Mirjana
    Zivojinovic, Sladjana
    Damjanov, Nemanja
    Spasovski, Vesna
    Srzentic, Sanja
    Stankovic, Biljana
    Pavlovic, Sonja
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (06) : 1481 - 1486